ArticleFrontiers in cell and developmental biology2021

Changes in N6-Methyladenosine Modification Modulate Diabetic Cardiomyopathy by Reducing Myocardial Fibrosis and Myocyte Hypertrophy.

Wenhao Ju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.